Skip to main content
SpringerLink
Log in

Hemostasis, cancer, and ABO blood group: the most recent evidence of association

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

Human ABO blood group antigens are expressed on the surface of red blood cells and a variety of human cells and tissues. However, an increasingly number of studies show that the ABO blood group, in addition to its fundamental role in transfusion medicine and in several other disciplines, has a causal role in predisposing to several human diseases, including hemostasis and neoplastic disorders, which will be the focus of this narrative review.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Preston AE, Barr A (1964) The plasma concentration of factor VIII in the normal population. Br J Haematol 10:238–245

    Article  CAS  PubMed  Google Scholar 

  2. Moeller A, Weippert-Kretschmer M, Prinz H, Kretschmer V (2001) Influence of ABO blood groups on primary hemostasis. Transfusion 2001:56–60

    Article  Google Scholar 

  3. O’Donnell JS, Lasffan MA (2001) The relationship between ABO histo-blood group, factor VIII and von Willebrand factor. Transfus Med 11:343–351

    Article  PubMed  Google Scholar 

  4. Gill JC, Endres-Brooks J, Bauer PJ, Marks WJ, Montgomery RR (1987) The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 69:1691–1695

    CAS  PubMed  Google Scholar 

  5. Koster T, Blann AD, Briët E, Vandenbroucke JP, Rosendaal FR (1995) Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 345:152–155

    Article  CAS  PubMed  Google Scholar 

  6. Folsom AR, Wu KK, Rosamond WD, Sharrett AR, Chambless LE (1997) Prospective study of hemostatic factors and incidence of coronary heart disease: the atherosclerosis risk in communities (ARIC) Study. Circulation 96:1102–1108

    Article  CAS  PubMed  Google Scholar 

  7. Whincup PH, Danesh J, Walker M et al (2002) Von Willebrand factor and coronary heart disease: prospective study and meta-analysis. Eur Heart J 23:1764–1770

    Article  CAS  PubMed  Google Scholar 

  8. Franchini M, Capra F, Targher G, Montagnana M, Lippi G (2007) Relationship between ABO blood group and von Willebrand factor levels: from biology to clinical implications. Thromb J 5:14

    Article  PubMed Central  PubMed  Google Scholar 

  9. Franchini M, Favaloro EJ, Targher G, Lippi G (2012) ABO blood group, hypercoagulability, and cardiovascular and cancer risk. Crit Rev Clin Lab Sci 49:137–149

    Article  CAS  PubMed  Google Scholar 

  10. Franchini M, Liumbruno GM (2013) ABO blood group: old dogma, new perspectives. Clin Chem Lab Med 51:1545–1553

    CAS  PubMed  Google Scholar 

  11. Franchini M, Makris M (2013) Non-O blood group: an important genetic risk factor for venous thromboembolism. Blood Transfus 11:164–165

    PubMed Central  PubMed  Google Scholar 

  12. Dick W, Schneider W, Brockmuller K, Mayer W (1963) Interrelations of thrombo-embolic diseases and blood group distribution. Thromb Diath Haemorrh 9:472–474

    Google Scholar 

  13. Wautrecht JC, Galle C, Motte S, Dereume JP, Dramaix M (1998) The role of ABO blood groups in the incidence of deep vein thrombosis. Thromb Haemost 79:688–689

    CAS  PubMed  Google Scholar 

  14. Tirado I, Mateo J, Soria JM et al (2005) The ABO blood group genotype and factor VIII levels as independent risk factors for venous thromboembolism. Thromb Haemost 93:468–474

    CAS  PubMed  Google Scholar 

  15. Ohira T, Cushman M, Tsai YM et al (2007) ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE). J Thromb Haemost 5:1455–1461

    Article  CAS  PubMed  Google Scholar 

  16. Wu O, Bayoumi N, Vickers MA, Clark P (2008) ABO(H) blood groups and vascular disease: a systematic review and meta-analysis. J Thromb Haemost 6:62–69

    Article  CAS  PubMed  Google Scholar 

  17. Dentali F, Sironi AP, Ageno W et al (2012) Non-O blood type is the commonest genetic risk factor for VTE: results from a meta-analysis of the literature. Semin Thromb Hemost 38:535–548

    Article  PubMed  Google Scholar 

  18. He M, Wolpin B, Rexrode K et al (2012) ABO blood group and risk of coronary heart disease in two prospective cohort studies. Arterioscler Thromb Vasc Biol 32:2314–2320

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  19. Franchini M, Rossi C, Mengoli C et al (2013) ABO blood group and the risk of coronary artery disease. J Thromb Thrombolysis 36:286–287

    Article  PubMed  Google Scholar 

  20. Jukic I, Bingulac-Popovic J, Dogic V et al (2013) Evaluation of ABO blood groups as a risk factor for myocardial infarction. Blood Transfus 11:464–465

    PubMed Central  PubMed  Google Scholar 

  21. Hanson E, Karlsson S, Jood K, Nilsson S, Blomstrand C, Jern C (2012) No evidence for an association between ABO blood group and overall ischemic stroke or any of the major etiologic subtypes. Thromb Res 130:339–342

    Article  CAS  PubMed  Google Scholar 

  22. Williams FM, Carter AM, Hysi PG et al (2013) Ischemic stroke is associated with the ABO locus: the EuroCLOT study. Ann Neurol 73:16–31

    Article  PubMed Central  PubMed  Google Scholar 

  23. Horwich L, Evans D, McConnell R, Donohoe W (1966) ABO blood groups in gastric bleeding. Gut 7:680–685

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  24. Evans D, Horwich L, McConnell R, Bullen M (1968) Influence of the ABO blood groups and secretor status on bleeding and on perforation of duodenal ulcer. Gut 9:319–322

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  25. Berg M (1969) Influence of age and ABO blood groups in the precipitation of bleeding peptic ulcers. Gut 10:1029–1030

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  26. Viskum K (1972) Long-term survival of patients with gastrointestinal hemorrhage with special reference to the ABO blood Groups. Scand J Gastroenterol 7:55–63

    Article  CAS  PubMed  Google Scholar 

  27. Reddy VM, Daniel M, Bright E, Broad SR, Moir AA (2008) Is there an association between blood group O and epistaxis? J Laryngol Otol 22:366–368

    Google Scholar 

  28. Bayan K, Tuzun Y, Yilmaz S, Dursun M, Canoruc F (2009) Clarifying the relationship between ABO/Rhesus blood group antigens and upper gastrointestinal bleeding. Dig Dis Sci 54:1029–1034

    Article  PubMed  Google Scholar 

  29. Kuyvenhoven JP, Veenendaal RA, Vanderbroucke JP (1999) Peptic ulcer bleeding: interaction between non-steroidal anti-inflammatory drugs, Helicobacter pylori infection and the ABO blood group system. Scand J Gastroenterol 34:1082–1086

    Article  CAS  PubMed  Google Scholar 

  30. Dentali F, Sironi AP, Ageno W et al (2013) Relationship between ABO blood group and hemorrhage: a systematic literature review and meta-analysis. Semin Thromb Hemost 39:72–82

    Article  PubMed  Google Scholar 

  31. Garcia AA, van der Heijden JF, Meijers JCM et al (2006) The relationship between ABO blood group and the risk of bleeding during vitamin K antagonist treatment. J Thromb Haemost 4:1418–1420

    Article  CAS  PubMed  Google Scholar 

  32. Pruissen DMO, Rosendaal FR, Gorter JW, Garcia AA, Kappelle LJ, Algra A (2007) Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin. J Neurol 254:1660–1665

    Article  CAS  PubMed  Google Scholar 

  33. Franchini M, Crestani S, Frattini F, Mengoli C, Bonfanti C (2012) Relationship between ABO blood group and bleeding complications in orally anticoagulated patients. J Thromb Haemost 10:1688–1691

    Article  CAS  PubMed  Google Scholar 

  34. Garratty G (2000) Blood groups and disease: a historical perspective. Transfus Med Rev 14:291–301

    Article  CAS  PubMed  Google Scholar 

  35. Seow LJ, Kwa SB, Teoh CK (1964) A preliminary survey of ABO blood group frequency in nasopharyngeal carcinoma in Chinese patients. Singapore Med J 4:93–95

    CAS  PubMed  Google Scholar 

  36. Turkoz FP, Celenkoglu G, Dogu GG (2011) Risk factors of nasopharyngeal carcinoma in Turkey—an epidemiological survey of the Anatolian Society of Medical Oncology. Asian Pac J Cancer Prev 12:3017–3021

    PubMed  Google Scholar 

  37. Sheng L, Sun X, Zhang L, Su D (2013) ABO blood group and nasopharyngeal carcinoma risk in a population of Southeast China. Int J Cancer 133:893–897

    Article  CAS  PubMed  Google Scholar 

  38. Joh HK, Cho E, Choueiri TK (2012) ABO blood group and risk of renal cell cancer. Cancer Epidemiol 36:528–532

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  39. Kaffenberger SD, Morgan TM, Stratton KL (2012) ABO blood group is a predictor of survival in patients undergoing surgery for renal cell carcinoma. BJU Int 110:E641–E646

    Article  PubMed  Google Scholar 

  40. Xie J, Qureshi AA, Li Y, Han J (2010) ABO blood group and incidence of skin cancer. PLoS ONE 5:e11972

    Article  PubMed Central  PubMed  Google Scholar 

  41. Gates MA, Wolpin BM, Cramer DW, Hankinson SE, Tworoger SS (2011) ABO blood group and incidence of epithelial ovarian cancer. Int J Cancer 128:482–486

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  42. Yuzhalin AE, Kutikhin AG (2012) ABO and Rh blood groups in relation to ovarian, endometrial and cervical cancer risk among the population of South-East Siberia. Asian Pac J Cancer Prev 13:5091–5096

    Article  PubMed  Google Scholar 

  43. Khalili H, Wolpin BM, Huang ES et al (2011) ABO blood group and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 20:1017–1029

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  44. Lee JS, Ro JY, Sahin AA et al (1991) Expression of blood-group antigen A—a favorable prognostic factor in non-small-cell lung cancer. N Engl J Med 324:1084–1090

    Article  CAS  PubMed  Google Scholar 

  45. Oguz A, Unal D, Tasdemir A et al (2013) Lack of any association between blood groups and lung cancer, independent of histology. Asian Pac J Cancer Prev 14:453–456

    Article  PubMed  Google Scholar 

  46. Urun Y, Utkan GA, Cangir K et al (2013) Association of ABO Blood Group and Risk of Lung Cancer in a Multicenter Study in Turkey. Asian Pac J Cancer Prev 14:2801–2803

    Article  PubMed  Google Scholar 

  47. Gates MA, Xu M, Chen WY, Kraft P, Hankinson SE, Wolpin BM (2012) ABO blood group and breast cancer incidence and survival. Int J Cancer 130:2129–2137

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  48. Miao SY, Zhou W, Chen L, Wang S, Liu SA (2013) Influence of ABO blood group and Rhesus factor on breast cancer risk: a meta-analysis of 9665 breast cancer patients and 244768 controls. Asia Pac J Clin Oncol. doi:10.1111/ajco.12083

    PubMed  Google Scholar 

  49. Bosetti C, Bertuccio P, Negri E, La Vecchia C, Zeegers MP, Boffetta B (2012) Pancreatic cancer: overview of descriptive epidemiology. Mol Carcinog 51:3–13

    Article  CAS  PubMed  Google Scholar 

  50. Aird I, Lee DR, Roberts IA (1960) ABO blood groups and cancer of oesophagus, cancer of pancreas, and pituitary adenoma. Br Med J 1:1163–1166

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  51. Macafee AL (1964) ABO blood groups and carcinoma of pancreas. Ulster Med J 33:129–131

    CAS  PubMed Central  PubMed  Google Scholar 

  52. Annese V, Minervini M, Gabbrielli A, Gambassi G, Manna R (1990) ABO blood groups and cancer of the pancreas. Int J Pancreatol 6:81–88

    CAS  PubMed  Google Scholar 

  53. Vioque J, Walker AM (1991) Pancreatic cancer and ABO blood types: a study of cases and controls. Med Clín 96:761–764

    CAS  Google Scholar 

  54. Wolpin BM, Chan AT, Hartge P et al (2009) ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst 101:424–431

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  55. Amundadottir L, Kraft P, Stolzenberg-Solomon RZ et al (2009) Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet 41:986–990

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  56. Wolpin BM, Kraft P, Gross M et al (2010) Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium. Cancer Res 70:1015–1023

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  57. Wolpin BM, Kraft P, Xu M et al (2010) Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the pancreatic cancer cohort consortium. Cancer Epidemiol Biomarkers Prev 19:3140–3149

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  58. Moran AP, Gupta A, Joshi L (2011) Sweet-talk: role of host glycosylation in bacterial pathogenesis of the gastrointestinal tract. Gut 60:1412–1425

    Article  CAS  PubMed  Google Scholar 

  59. Rizzato D, Campa D, Pezzilli R et al (2013) ABO blood groups and pancreatic cancer risk and survival: results from the PANcreatic Disease ReseArch (PANDoRA) consortium. Oncol Rep 29:637–644

    Google Scholar 

  60. Iodice S, Maisonneu P, Botteri E, Sandri MT, Lowenfels AB (2010) ABO blood group and cancer. Eur J Cancer 46:3345–3350

    Article  CAS  PubMed  Google Scholar 

  61. Pelzer U, Klein F, Bahra M et al (2013) Blood group determinates incidence for pancreatic cancer in Germany. Front Physiol 24:118

    Google Scholar 

  62. Risch HA, Lu L, Wang J et al (2013) ABO blood group and risk of pancreatic cancer: a study in Shanghai and meta-analysis. Am J Epidemiol 177:1326–1337

    Article  PubMed Central  PubMed  Google Scholar 

  63. Risch HA, Yu H, Lu L, Kidd MS (2010) ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: a case–control study. J Natl Cancer Inst 102:502–505

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  64. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90

    Article  PubMed  Google Scholar 

  65. Aird I, Bentall HH, Fraser Roberts JA (1953) A relationship between cancer of stomach and the ABO blood groups. Br Med J 1:799–801

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  66. Clarke CA (1961) Blood group and disease. In: Steiberg AG (ed) Progress in medical genetics. Grune and Stratton, New York, pp 81–119

    Google Scholar 

  67. Garratty G (1994) Do blood groups have a biological role? In: Garratty G (ed) Immunobiology of transfusion medicine. Marcel Dekker, Inc., New York, pp 201–255

    Google Scholar 

  68. Edgren G, Hjalgrim H, Rostgaard K et al (2010) Risk of gastric cancer and peptic ulcers in relation to ABO blood type: a cohort study. Am J Epidemiol 172:1280–1285

    Article  PubMed  Google Scholar 

  69. Wang Z, Liu L, Ji J et al (2012) ABO blood group system and gastric cancer: a case–control study and meta-analysis. Int J Mol Sci 13:13308–13321

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  70. Rizzato C, Kato I, Plummer M et al (2013) Risk of advanced gastric precancerous lesions in Helicobacter pylori infected subjects is influenced by ABO blood group and cagA status. Int J Cancer 133:315–322

    Article  CAS  PubMed  Google Scholar 

  71. Nakao M, Matsuo K, Ito H et al (2011) ABO genotype and the risk of gastric cancer, atrophic gastritis, and Helicobacter pylori infection. Cancer Epidemiol Biomarkers Prev 20:1665–1672

    Article  PubMed  Google Scholar 

  72. Song HR, Shin MH, Kim HN et al (2013) Sex-specific differences in the association between ABO genotype and gastric cancer risk in a Korean population. Gastric Cancer 16:254–260

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

G M. Liumbruno and M. Franchini declare that there is no conflict of interests regarding the publication of this article.

Author information

Authors and Affiliations

  1. UOC di Immunoematologia e Medicina Trasfusionale e UOC di Patologia Clinica, San Giovanni Calibita Fatebenefratelli Hospital, Rome, Italy

    Giancarlo Maria Liumbruno

  2. Dipartimento di Medicina Trasfusionale ed Ematologia, Azienda Ospedaliera Carlo Poma, Mantua, Italy

    Massimo Franchini

Authors
  1. Giancarlo Maria Liumbruno
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Massimo Franchini
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Massimo Franchini.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liumbruno, G.M., Franchini, M. Hemostasis, cancer, and ABO blood group: the most recent evidence of association. J Thromb Thrombolysis 38, 160–166 (2014). https://doi.org/10.1007/s11239-013-1027-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-013-1027-4

Search

Navigation